Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Title

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Recent News - Mar. 16, 2021

Congratulations to our colleagues at Cambridge Consultants, who today announced their role in the development of the first fully at-home, prescription-free COVID-19 test to receive U.S. Government Emergency Use Authorization.

The ground-breaking optics technology devised by Cambridge Consultants, coupled with Ellume’s supercharged fluorescent immunochromatography, enabled these sensitive measurements to be performed at home with 96% accuracy.

Learn more about the breakthrough technology on the Cambridge Consultants website.

Other News

Synapse is now officially Climate Neutral Certified

Synapse is proud to announce that we are officially Climate Netural Certified.

Compology selected as one of Fast Company's top 10 most innovative social good companies of 2022

Compology's waste metering technology highlighted as a game-changing sustainability initiative

Patent Granted for Synapse Project With Cutsforth™

We are extremely proud to announce that a